Corrigendum: Pathogenetic, Prognostic, and Therapeutic Role of Fatty Acid Synthase in Human Hepatocellular Carcinoma.

FASN de novo lipogenesis hepatocellular carcinoma precision medicine tumor metabolism

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2022
Historique:
received: 11 02 2022
accepted: 24 03 2022
entrez: 2 5 2022
pubmed: 3 5 2022
medline: 3 5 2022
Statut: epublish

Résumé

[This corrects the article DOI: 10.3389/fonc.2019.01412.].

Identifiants

DOI: 10.3389/fonc.2022.874053 PMID: 35494002 PMC: PMC9040444
pubmed: 35494002
doi: 10.3389/fonc.2022.874053
pmc: PMC9040444
doi:

Types de publication

Published Erratum

Langues

eng

Pagination

874053

Commentaires et corrections

Type : ErratumFor

Informations de copyright

Copyright © 2022 Che, Paliogiannis, Cigliano, Pilo, Chen and Calvisi.

Auteurs

Li Che (L)

Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, San Francisco, San Francisco, CA, United States.

Panagiotis Paliogiannis (P)

Department of Medical, Surgical and Experimental Medicine, University of Sassari, Sassari, Italy.

Antonio Cigliano (A)

Institut für Pathologie, Universität Regensburg, Regensburg, Germany.

Maria G Pilo (MG)

Department of Medical, Surgical and Experimental Medicine, University of Sassari, Sassari, Italy.

Xin Chen (X)

Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, San Francisco, San Francisco, CA, United States.

Diego F Calvisi (DF)

Department of Medical, Surgical and Experimental Medicine, University of Sassari, Sassari, Italy.

Classifications MeSH